Found 8 matching trials
Second Open Label Extension to Bridging Study CTBM100C2303 PHASE3 This was an open-label, single arm (uncontrolled) study in participants suf...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI) PHASE4 The purpose of this interventional Phase IV study was to explore the ease o...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis PHASE3 This study compares the safety of the tobramycin solution for inhalation wi...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis PHASE4 This study assessed the long term safety data for the use of tobramycin inh...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Inhalation Flow Rate-study PHASE1 Study should show feasibility of the device for drug delivery into the lung...
Show More Location
Multiple Locations
Learn More & Join Trial
Open Label Extension to Bridging Study CTBM100C2303 PHASE3 This was an open-label, single arm (uncontrolled) study in participants suf...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) PHASE3 The purpose of this study is to evaluate if the time to first pulmonary exa...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo PHASE3 This study is designed to show how well tobramycin inhalation powder works ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial